Iodinated contrast media supports clinical decision-making across emergency, cancer, cardiovascular and routine imaging, but rising demand, supply constraints and inefficient use place growing pressure on services. Recent shortages have forced organisations to alter protocols, redirect care or delay examinations, exposing weaknesses in supply resilience. A five-level stewardship approach moves from reactive rationing towards targeted waste reduction, standardised workflows, more appropriate ordering and executive governance. It treats contrast as a finite strategic resource and links efficient use with lower waste, reduced operational strain, environmental performance and continued access to contrast-enhanced imaging without compromising diagnostic quality.
From Reactive Rationing to Routine Efficiency
The first level reflects organisations without a standing stewardship programme. Fixed-dose protocols are rarely reviewed, waste is not measured and shortages prompt emergency rationing, protocol changes or imaging delays. Once supply normalises, previous practices return and temporary efficiency gains are lost. This leaves services exposed to disruption and allows avoidable cost, packaging waste and environmental burden to continue. Fixed doses designed around average patients may also give smaller patients more contrast than needed and provide insufficient doses for larger patients.
Progress begins with auditing contrast use and waste, comparing administered doses with patient weight patterns and reviewing high-volume examinations. Previous shortage responses can identify which changes were clinically workable, which added administrative or workforce pressure and which remained in place. A named stewardship lead within imaging or supply chain helps retain ownership during operational surges.
At the second level, organisations reduce waste without changing the imaging-ordering pathway. Fixed volumes can be replaced with weight-based dosing where appropriate. Teams can match vial size to the required dose, assess end-of-day waste, improve stock rotation and align deliveries with actual use. Where clinically appropriate, bulk or multi-dose formats can reduce per-exam packaging waste, disposal costs and discarded contrast. Scanner settings and available technologies can support lower doses in selected applications. These measures can be introduced within existing pathways and provide a basis for more consistent practice.
Must Read: Rethinking Iodine Use to Support Sustainable Radiology
Embedding Stewardship Across Clinical Workflows
The third level moves iodine stewardship from individual behaviour into routine infrastructure. Protocols, training, onboarding, standard operating procedures and quality audits establish common practice across staff, shifts, scanners and locations. Persistent variation in contrast use becomes a target for review, while waste rates and workflow performance are monitored during normal operations and periods of pressure. This reduces reliance on the knowledge or habits of particular individuals and helps improvements survive turnover, volume increases and supply fluctuation.
Standardisation also addresses workforce strain. Imaging volumes are projected to grow faster than staffing, and unnecessary variation adds cognitive and operational burden. Consistent procedures allow clinical teams to focus more attention on patients instead of repeatedly managing different local practices. Stable infrastructure also improves crisis readiness because conservation measures are already embedded rather than improvised during a shortage.
The fourth level shifts attention upstream to whether an examination should be ordered and which modality is most appropriate. Clinical decision support can guide referrals, while radiologists and referring clinicians can jointly develop credible ordering guidance. Ongoing review can prevent avoidable repeat imaging caused by poor system integration. Alternative modalities, including contrast-enhanced ultrasound, gadolinium-based MRI or barium-based oral contrast, may reduce iodinated contrast use in defined clinical situations. They do not replace contrast-enhanced CT when CT remains the appropriate option. Removing low-value imaging also preserves department capacity and reduces radiation exposure, environmental effects and total care costs.
Governance Extends Reform Beyond Imaging
The highest level makes iodine stewardship an organisational priority with executive ownership, defined indicators, cross-functional governance and regular reporting. Oversight is integrated into established quality, sustainability and operational structures rather than placed in a separate programme. Joint responsibility between imaging and supply chain can connect clinical use with procurement, resilience and environmental goals. A limited set of indicators may cover utilisation by volume and per patient, waste rates, protocol compliance, imaging appropriateness, environmental performance and workforce measures.
This level also extends responsibility beyond a single institution. Organisations can share practices and outcomes with professional societies, peer institutions and policy bodies. Common benchmarks for contrast use, waste and environmental impact remain undeveloped, limiting comparison and broader progress. Manufacturers also have responsibilities linked to iodine reclamation, packaging innovation and transparency about production capacity, while health systems focus on internal use and governance. Conservation can make more contrast available to patients and institutions with fewer resources or greater vulnerability to disruption.
Future options remain uncertain. Synthetic or virtual contrast tools that aim to produce contrast-like images from non-contrast scans are still experimental and not routinely approved or deployed. They require further technical development, clinical validation and regulatory review. Biodegradable alternatives and new imaging agents are also areas of interest. Contrast recovery programmes after patient administration exist at different stages in several countries, but logistical and regulatory complexity currently prevents use at scale.
Iodine stewardship develops through deliberate stages rather than a single system-wide overhaul. Initial audits and targeted waste reduction can establish practical gains, while standardised workflows make them durable. Ordering reform then reduces avoidable contrast-enhanced imaging before contrast is prepared. Executive ownership, governance and meaningful indicators support long-term accountability across clinical, operational and sustainability priorities. The model connects dosing, ordering, procurement and leadership rather than treating contrast use as an isolated departmental concern. By moving beyond emergency conservation, health systems can protect access to necessary imaging, reduce waste and strengthen resilience against future supply disruption.
Source: Advisory Board
Image Credit: iStock
